Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Pharmacology

  • Article

    90-Day Mortality Among Septic Patients Given Piperacillin-Tazobactam Versus Cefepime

    January 1, 2025

    Clinical question: In patients with undifferentiated sepsis without an indication for anaerobic coverage, is there increased mortality with the combined use of vancomycin/piperacillin-tazobactam...

  • Article

    Hydrocortisone Plus Fludrocortisone for CAP-Related Septic Shock

    January 1, 2025

    Clinical question: Does hydrocortisone and fludrocortisone reduce all-cause mortality among patients with septic shock due to community-acquired pneumonia (CAP)? Background: A meta-analysis of 17...

  • Article

    Empagliflozin After Acute Myocardial Infarction (EMPACT-MI)

    January 1, 2025

    Clinical question: Does starting empagliflozin for patients with acute myocardial infarction (AMI) and new onset systolic heart failure (HF) or congestive symptoms reduce the risk of first...

  • Article

    Illicit Medetomidine Use with Fentanyl

    January 1, 2025

    Medetomidine is a non-opioid veterinary anesthetic drug and a synthetic alpha-2-adrenoceptor agonist that is not approved for human use. Increasingly, it’s being used with illicitly manufactured...

  • Early Switch to Oral Antimicrobial Therapy for Staphylococcus aureus Bacteremia

    November 1, 2024

    Dr. Toy Clinical question: Is an early switch to oral antimicrobial therapy in low-risk Staphylococcus aureus bloodstream infection non-inferior to standard intravenous antimicrobial...

  • Article

    GLP-1 RA Use is Associated with Increased Residual Gastric Contents in Appropriately Fasted Patients Before Elective Procedures

    November 1, 2024

    Drr. Taylor Clinical question: Does Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) use lead to an increased risk of aspiration in patients undergoing anesthesia for elective...

  • Article

    Opioid Prescribing and Outcomes in Patients with SCD Post-2016 CDC Guideline

    November 1, 2024

    Dr. Klubnick Clinical question: Did the 2016 U.S. Centers for Disease Control and Prevention (CDC) guideline for prescribing opioids for chronic pain change opioid prescribing practices and...

  • Article

    Early Switch from IV to Oral Antibiotics for Uncomplicated Gram-Negative Bacteremia

    November 1, 2024

    Dr. Shindo Clinical question: Is there a mortality difference between early transition to oral antibiotics versus prolonged intravenous antibiotics in uncomplicated gram-negative...

  • Article

    SGLT-2 inhibitors May Decrease Recurrent Gout Flares in Patients with Type 2 diabetes

    May 1, 2024

    Dr. Bernal Clinical question: Do SGLT-2 inhibitors decrease gout flares in patients with type 2 diabetes and a known history of gout? Background: Sodium–glucose cotransporter-2 inhibitors...

  • Article

    Semaglutide in Patients with HFpEF and Obesity

    May 1, 2024

    Dr. Cepeda Mora Clinical question: Is semaglutide an effective heart failure treatment in patients with heart failure with preserved ejection fraction (HFpEF) and obesity? Background: HFpEF is...

Previous1 2 3 4 … 13Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences